Chart 1_S&P500 chart 26 Feb 23

U.S & European stocks logged their largest weekly falls for 2023. What’s next for the equity markets? (26 Feb 23)

Dear all With reference to my writeup published on 30 Jan 2023 (click HERE), where I mentioned I would be cautious in the overall markets, especially after a sharp run up, US stocks have dropped consecutively for the in the past three weeks. Dow has fallen consecutively for the past three weeks and logged its sharpest 1,010 points or 3.0% last week.   So, what is next for our markets? Do we buy, hold or sell? Just to highlight, the below is a sample of a brief stock alert or / and observation which I typically send to my clients […]

Figure 1_Raffles Medical ANR 20 Feb 23

Raffles Medical – Potential trading play as its results are just around the corner (20 Feb 23)

Dear all, Raffles Medical caught my attention recently as CLSA raised its target price from $1.70 to $1.92 on 8 Feb 23. $1.92 is a street high target with most analysts’ target price ranging between $1.58 – 1.65. Raffles Medical closed down 1 cent to $1.45 last Fri. Based on my personal view and observation, generally speaking, analysts seldom issue updated call so near to the company’s results release date. I mean there is usually no such urgency to do so, unless they have a significant change in view on the company. For those analysts who do, their calls are […]

Fig 1_Kep Corp analyst target 7 Feb 23

Keppel Corp slumps 7% post results to $7.11 – Any trading opportunity ahead? (8 Feb 23)

Dear all, Kep Corp has fallen $0.54 or 7% from $7.65 on 2 Feb to close $7.11 yesterday. In this write-up, I will elaborate on my take on what has happened and whether there is any trading opportunity.   Why did Kep Corp plummet 7%? Kep Corp announced 4QFY22 results on 2 Feb after market. Based on CGS-CIMB report, Kep Corp’s FY22 net profit of S$927m slightly beat estimates, at 102% consensus estimates. So what has caused the sharp drop in share price post results? My guess is that Kep Corp probably drops because a) Kep Corp has appreciated 7.6% […]

Chart 1_Tianjin 2Y price chart

Tianjin Pharma – A potential undervalued company, net cash; rides on favourable tailwinds (24 Dec 22)

Dear all Last Friday, personal protection equipment (“PPE”) and glovemakers rallied as much as 3% – 36% in a single day (See Table 1 below). This outperformance may be attributed to concerns that the Covid situation in China may worsen with more infections, or may cause the appearance of new variants, which may spur demand for gloves and personal protection equipment. Table 1: SG glovemakers and PPE share price performance on Friday Source: Ernest’s manual compilations 23 Dec 22 Personally, besides PPE and glovemakers which may benefit, Tianjin Pharmaceutical Da Ren Tang Group (“T14”) may be another potential and perhaps […]

Table 1_Highlighted companies on my blog and their performance 3 Dec 22

Nov has been a fantastic month for equities! What’s next? (3 Dec 22)

Dear all With reference to my writeup published on 25 Oct (click HERE), where markets seem to be plagued with various negative news, I pointed out that Dow may have formed a bullish double bottom formation. In the writeup, I also featured Hang Seng tracker ETF (2800.HK) and UOB. My clients would have noticed my almost daily writeups on the stocks to consider taking a closer look as they hit lows in Oct. Below are only some of the stocks which I have featured on my blog in Oct and their performance. Table 1: Featured writeups on my blog in […]

Figure 1_UOB analyst target price 25 Oct 22

Dow seems to have formed a bullish double bottom formation (25 Oct 2022)

Dear all Talk to anyone and I guess at least 50% of them are shaking their heads. Some of their usual concerns are a) Anxieties on the economy and their jobs in 2023; b) Hit by inflationary pressures from rising costs ranging from food, fuel, electricity, cars and properties; c) Worries over their home mortgage as rates are soaring through the roof; d) Concerns on their portfolios whether there may be more losses ahead and etc… At the point of writing this article, Hang Seng closed -1,030 points lower, or -6.4% to close 15,181. Is it all doom and gloom? […]

Figure 1_Comfort Delgro analyst target price 30 Sep 22

Comfort Delgro drops back to pandemic lows! What gives? (30 Sep 22)

On 1 Sep, it was announced that Comfort Delgro (“CD”) will drop out of STI after being first included in the STI on 28 Jul 2010. Subsequently, there was turmoil in United Kingdom (“UK”) gilts and currency as UK government led by Prime Minister Liz Truss unveiled a (surprisingly) GBP45b plan to reduce taxes (click HERE for more information). Although CD may see some near-term price weakness, at Friday’s close of $1.32 (CD touched an intraday low $1.29 at the point of writing this), I personally believe most of the negatives may have already been priced in. Why am I […]

Table 1_Top ten stocks sorted by total potential return 29 Jul 22

Numerous trading opportunities as Singapore corporates report results (9 Aug 2022)

Dear all, Happy National Day! How has your portfolio been year to date? With reference to my writeup published on 3 Jul 2022 (click HERE), I mentioned that there are likely to be opportunities in the next few weeks. Post my writeup, S&P500 touched an intraday low of 3,722 on 14 Jul before closing up 418 points or 11.2% at 4,140 yesterday. In fact, S&P500 posted its best monthly gain in July, since Nov 2020. STI touched an intraday low of 3,088 on 15 Jul before trading up 183 points or 5.9% at 3,271 yesterday. Our Singapore banks started to […]

Table 1_Bloomberg est on Comfort Delgro's 1HFY22F interim dividends 5 Aug 22

Alert! Comfort Delgro – Multi-month base building & challenges key resistance – Looks bullish (6 Aug 22)

Dear Readers, As you are aware, I usually will do a stock screening using Bloomberg at the start of each month. In the screening, Comfort Delgro (“CD”) pops out on attractive valuations via my metrics. This is not the first time that CD pops out in my screening. However, coupled with some of the points below, it may arguably be a good time to take a closer look in CD. Due to time constraints, this write-up will be brief and I will just raise some pertinent points and risks. For a more complete picture, it is advisable to refer to […]